C-reactive protein and sleep-disordered breathing

Sleep

Volumn 27, Issue 8, 2004, Pages 1507-1511

  Guilleminault, Christian ^a   Kirisoglu, Ceyda ^a   Ohayon, Maurice M ^b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

C reactive protein; Obesity; Obstructive sleep apnea; Respiratory disturbance index; Upper airway resistance syndrome

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AIRWAY RESISTANCE; ARTICLE; BLOOD OXYGEN TENSION; COMORBIDITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY DISTURBANCE INDEX; RESPIRATORY FUNCTION; RISK FACTOR; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP PARAMETERS; SYNDROME; UPPER AIRWAY RESISTANCE SYNDROME; UPPER RESPIRATORY TRACT;

EID: 11144256430     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/27.8.1507     Document Type: Article

References (27)

1. Ridker PM, Rifai N, Rose L, Buring J, Cook N. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
2. Ridker PM, Curing JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 2003;107:391-397
3. Lemieux I, Pascot A, Prud'homme D, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arteroscler Thromb Vasc Biol 2001;21:961-7.
4. Frohlich M, Imhof A. Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome. Diab Care 2000;23:1835-9.
5. McLaughlin T, Abbasi F, Lamendola C, et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002;106:2908-12.
6. Strohl KP, Novak RD, Singer W, et al. Insulin level, blood pressure and sleep apnea. Sleep 1994;17:614-618.
7. Shamsuzzaman ASM, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002;105:2462-4.
8. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure Circulation 2003;107:1129-34.
9. Cheng TO. Could elevated C-reactive protein in patients with obstructive sleep apnea be due to obesity per se? Circulation 2003;107:9.
10. Guilleminault C, Chowdhuri S. Upper airway resistance syndrome is a distinct syndrome. Am J Respir Crit Care Med 2000;161:1412-3.
11. Miles L. Sleep questionnaire and assessment of wakefulness. In: Guilleminault C, ed. Sleeping and Waking Disorders: Indications and Techniques. Menlo-Park CA: Addison Wesley; 1982:383-413.
12. Johns MW. A new method for measuring daytime sleepiness, the Epworth Sleepiness Scale. Sleep 1991;14:540-5.
13. Chervin RD. Sleepiness, fatigue, tiredness and lack of energy in obstructive sleep apnea. Chest 2000;118:372-9.
14. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Arch Neurol 1989;46:1121-3.
15. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993;37:147-53.
16. Mallampati SR, Gatt SP, Gugino LD, et al. A clinical sign to predict difficult tracheal intubation: a prospective study. Can Anaesth Soc J 1985;32:429-34.
17. American Academy of Sleep Medicine Task force: sleep-related breathing disorders in adults: recommendations for syndrome definition and measurements techniques in clinical research. Sleep 1999;22:667-89.
18. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-84.
19. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human Subjects. Los Angeles: Brain Information Service/Brain Research Institute, UCLA; 1968.
20. Tamakoshi K, Yatsuya H, Kondo T, et al. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systematic low-grade inflammatory state. Int J Obes Relat Metab Disord 2003; 27:443-9.
21. Pieroni L, Bastard JP, Piton A, Khalif L, Hainque B, Jardel C. Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. Diabetics Metab 2003;29:133-8.
22. Basiri A, Guilleminault C. Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome. In: Kryger MH, Roth T, Dement WC, eds. Principle and Practice of Sleep Medicine. Philadelphia: Saunders; 2000:869-78.
23. Guilleminault C, Li K, Chen NH, Poyares D. Two-point palatal discrimination in patients with upper airway resistance syndrome, obstructive sleep apnea syndrome, and normal controls. Chest 2002;122:866-70.
24. Guilleminault C, Kim YD, Stoohs RA. Upper airway resistance syndrome. Oral Maxillofac Surg Clin North Am 1995;7:243-6.
25. Guilleminault C, Kim YD, Chowdhuri S, Horita M, Ohayon M, Kushida C. Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnea syndrome. Eur Respir J 2001;17:1-10.
26. Guilleminault C, Faul J L, Stoohs R. Sleep-disordered breathing and hypotension. Am J Respir Crit Care Med 2001;164:1242-7.
27. Guilleminault C, Palombini L, Poyares D, Chowdhury S. Chronic insomnia, postmenopausal women, and sleep-disordered breathing. Part 2: Comparison of nondrug treatment trials in normal breathing and UARS postmenopausal women complaining of insomnia. J Psychosom Res 2002;53:617-23.